Alan Mendelsohn

Insider Reports History

Entity
Individual
Location
C/O Timber Pharmaceuticals, Inc., 50 Tice Blvd., Suite A26, Woodcliff Lake, NJ
Signature
/s/ Joseph Lucchese, Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Mendelsohn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Timber Pharmaceuticals, Inc. EVP & CMO Common Stock, par value $0.001 per share 35.4K $57.7K $1.63 Aug 20, 2023 Direct
Timber Pharmaceuticals, Inc. EVP & CMO Common Stock, par value $0.001 per share 39 $63.50 $1.63 Aug 20, 2023 By spouse
Timber Pharmaceuticals, Inc. EVP & CMO Stock Option (right to buy) 22.5K Apr 15, 2023 Direct

Insider Reports Filed by Alan Mendelsohn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TMBR Timber Pharmaceuticals, Inc. Aug 20, 2023 1 $0 4 Aug 22, 2023 EVP & CMO
TMBR Timber Pharmaceuticals, Inc. Apr 15, 2023 1 $0 4 Apr 18, 2023 EVP & CMO
TMBR Timber Pharmaceuticals, Inc. Apr 15, 2022 1 $0 4 Apr 19, 2022 Chief Medical Officer
TMBR Timber Pharmaceuticals, Inc. Nov 23, 2021 1 $4.7K 4 Nov 24, 2021 Chief Medical Officer
TMBR Timber Pharmaceuticals, Inc. Jul 1, 2021 1 $0 4 Jul 6, 2021 Chief Medical Officer
TMBR Timber Pharmaceuticals, Inc. Mar 3, 2021 1 $4.31K 4 May 13, 2021 Chief Medical Officer